The Schall Law Firm Is Conducting A Probe Into Accusations Against MacroGenics Inc And Calls On Its Shareholders To Make Contact
- 29
LOS ANGELES, CA / ACCESSWIRE / June 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of MacroGenics, Inc. ("MacroGenics" or "the Company") (NASDAQ:MGNX) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. MacroGenics provided investors with a clinical trial update as part of its recent earnings report, admitting that 5 patients had died during its TAMARACK study. Based on this news, shares of MacroGenics dropped by more than 70% on May 10, 2024.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]
SOURCE: The Schall Law Firm
View the original press release on accesswire.com
ACCESSWIRE is a premier news and communications network, providing regional, national, and global news to hundreds of clients globally. In addition to our world class and ever growing distribution network, ACCESSWIRE is also leading the way in social engagement, targeting and analytics.
